Clinical Trials Logo

Gastroesophageal Reflux Disease clinical trials

View clinical trials related to Gastroesophageal Reflux Disease.

Filter by:

NCT ID: NCT01212835 Terminated - Morbid Obesity Clinical Trials

Effect of RING on Gastroesophageal Reflux (GERD) After RYGBP

RING
Start date: October 2010
Phase: N/A
Study type: Interventional

Silastic rings have been used around the gastric pouch in order to promote better weight loss after Roux-and-Y gastric bypass surgery ( RYGBP). However the investigators have shown that some patients developed gastroesophageal reflux disease after RYGBP in a previous study. The investigators hypothesized that the use of a silastic ring may play a role in promoting GERD after this operation.

NCT ID: NCT01212614 Completed - Healthy Volunteers Clinical Trials

Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients

Start date: October 2010
Phase: N/A
Study type: Interventional

This study bases on the successfully completed project SNF 320000-112006 (EK 1152 and SwissMedic 2005dr2207e) and will document the physiological effects of inhibited gastric secretion on the volume as well as the acidity of gastric secretion by high dose proton pump inhibitors in GERD patients and healthy controls. Twelve participants in each group will be studied in a randomized, double-blind placebo controlled trial. A novel non-invasive MRI technique developed in Zurich will assess the volume of gastric secretion following the ingestion of a regular liquid meal. In addition, intragastric / esophageal pH monitoring will assess the link between volume and intragastric distribution of gastric secretion on reflux events and symptoms. In addition, the effect of gastric secretion on outcome parameters of a non-invasive stable isotope breath test for measurement of gastric emptying will be assessed.

NCT ID: NCT01204931 Completed - Clinical trials for Gastroesophageal Reflux Disease

Can We Predict Who Has Gastroesophageal Reflux Disease (GERD)?

Start date: November 2010
Phase: N/A
Study type: Observational

Gastroesophageal reflux disease (GERD) is currently defined as "a condition which develops when the reflux of stomach contents causes troublesome symptoms and/or complications". Doctors often diagnose and treat GERD based on symptoms of heartburn and regurgitation. In recent years, the prevalence of partial or non-response to Proton Pump Inhibitors (PPI) has increased resulting in diagnostic testing with esophagogastroduodenoscopy (EGD) or ambulatory pH monitoring. Most patients do not have endoscopic evidence for reflux. Thus, in this group pH monitoring has emerged as an important physiologic test to determine the degree of esophageal acid exposure and to assess the association between patients' persistent symptoms and acid reflux events. The aims of this study are to assess the sensitivity and specificity of symptom associated indices and determine the best parameter for predicting GERD from a list of conventional pH measurement findings.

NCT ID: NCT01200550 Completed - Clinical trials for Gastroesophageal Reflux Disease

The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients

Start date: September 2010
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate symptoms control and impact on daily life from patients perspective using specific GERD Impact Scale(GIS) questionnaire. The another objective is to obtain local epidemiological data for Bosnia and Herzegovina regarding GERD treatment in primary care.

NCT ID: NCT01199679 Terminated - Clinical trials for Gastroesophageal Reflux Disease

Rubber Band Ligation and Mucosectomy for Gastroesophageal Reflux Disease (GERD)

GERD
Start date: June 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the safety and effectiveness of two separate procedures to treat gastroesophageal reflux disease (GERD) also known as heartburn. The two therapies are: 1) a banding procedure alone using the Cook® 6 Shooterâ„¢ Saeed Multi-Band Ligator or 2) a banding/shaving procedure called Endoscopic Mucosal Resection (EMR) using the Cook® Duetteâ„¢ Multi-Band Mucosectomy device.

NCT ID: NCT01161602 Completed - Clinical trials for Gastroesophageal Reflux Disease

A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if pumosetrag is effective in treating Gastroesophageal Reflux Disease (GERD) symptoms in patients who have a history of GERD symptoms and are currently taking an acid suppression therapy, such as a Proton Pump Inhibitor (PPI).

NCT ID: NCT01149395 Completed - Clinical trials for Gastroesophageal Reflux Disease

Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn

Start date: June 2010
Phase: Phase 1
Study type: Interventional

The purpose of this research study is to determine in heartburn patients with nonerosive disease if detecting the presence of a fragment of the protein e-cadherin in esophageal epithelium or the amount of fragments of e-cadherin in blood can be used to monitor healing of esophagitis treated with a proton pump inhibitor (PPI). The hypothesis is that the presence of fragments of e-cadherin in esophageal epithelium or the amount of fragments of e-cadherin in blood can you useful as a biomarker for the healing of esophagitis in patients successfully treated with a PPI.

NCT ID: NCT01136980 Completed - Clinical trials for Gastroesophageal Reflux Disease

Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study

RESPECT
Start date: April 2011
Phase: N/A
Study type: Interventional

The objective of the study is to evaluate the relative merits, safety and effectiveness of the EsophyX transoral device in performing an advanced TIF procedure in patients with "troublesome symptoms" as defined by the Montreal consensus definition while on PPIs compared with sham and placebo controls.

NCT ID: NCT01128608 Unknown status - Clinical trials for Gastroesophageal Reflux Disease

The Effect of High PCO2 Solution on Esophageal Acid Sensation

PC02
Start date: September 2009
Phase: N/A
Study type: Interventional

To determine the effect of intraesophageal high PCO2 solution as compared to acidic and saline solutions on subjects' heartburn sensation using stiumlus-response functions.

NCT ID: NCT01128582 Active, not recruiting - Clinical trials for Gastroesophageal Reflux Disease

Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia.

Rozerem
Start date: March 2009
Phase: Phase 3
Study type: Interventional

To determine if administration of Rozerem in comparison to a placebo reduces or eliminates gastroesophageal reflux disease(GERD) symptoms in individuals with both GERD and chronic insomnia.